View source for Reference:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 2 Paragraph 67–69

{{#set:
|HasDocument=Document:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023
|RefScope=IVD
|RefDocPart=Article 2 
Paragraph 67–69
|RefLanguage=EN
|RefTagsEN=
|RefTagsOriginal=
|RefTagsFR=
}}

{{:Document:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023}}

{| class="wikitable gplx-infobox"
|-
! colspan="2" class="gplx-infobox-header" | Reference Details
|-
! Scope
| IVD
|-
! Document part
| Article 2 
Paragraph 67–69
|-
! Language
| EN
|-
! Original entry by
| Florian Adragna
|-
! Contributors
| 
|-
! Tags (EN)
| 
|-
! Tags (original language)
| 
|-
! Tags (FR)
| 
|-
! Comment
| Definition of incident (IVDR)
|}

== Content ==
(67) ‘incident’ means any malfunction or deterioration in the characteristics or performance of a device made available on the market, including use-error due to ergonomic features, as well as any inadequacy in the information supplied by the manufacturer and any harm as a consequence of a medical decision, action taken or not taken on the basis of information or result(s) provided by the device;

(68) ‘serious incident’ means any incident that directly or indirectly led, might have led or might lead to any of the following:

(a) the death of a patient, user or other person,

(b) the temporary or permanent serious deterioration of a patient's, user's or other person's state of health,

(c) a serious public health threat;

(69) ‘serious public health threat’ means an event which could result in imminent risk of death, serious deterioration in a person's state of health, or serious illness, that may require prompt remedial action, and that may cause significant morbidity or mortality in humans, or that is unusual or unexpected for the given place and time;